Cargando…
AMP‐activated protein kinase β1 or β2 deletion enhances colon cancer cell growth and tumorigenesis: Effects of AMPKβ1 or β2 deletion in colon cancer
Abnormal metabolism is a major hallmark of cancer and has been validated as a therapeutic target. Adenine monophosphate‐activated protein kinase (AMPK), an αβγ heterotrimer, performs essential functions in cancer progression due to its central role in maintaining the homeostasis of cellular energy....
Autores principales: | Shi, Fuli, Tang, Zhimin, Jiang, Shanshan, Xiong, Zhijuan, Zhang, Wansi, Li, Yuanjun, Lin, Hui, Luo, Zhijun, Ying, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828713/ https://www.ncbi.nlm.nih.gov/pubmed/35880569 http://dx.doi.org/10.3724/abbs.2022086 |
Ejemplares similares
-
Morphine dependence in single enteric neurons from the mouse colon requires deletion of β‐arrestin2
por: Smith, Tricia H., et al.
Publicado: (2014) -
LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells
por: Li, Nian-Shuang, et al.
Publicado: (2015) -
Protein Kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity
por: Sundram, Vasudha, et al.
Publicado: (2014) -
AMPK inhibits Smad3‐mediated autoinduction of TGF‐β1 in gastric cancer cells
por: Zou, Junrong, et al.
Publicado: (2021) -
β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model
por: Moran-Jones, Kim, et al.
Publicado: (2012)